Viewing Study NCT01482156


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2025-12-25 @ 9:10 PM
Study NCT ID: NCT01482156
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2011-09-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module